[VRDN] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
24-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -11.88%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 4,461 8,386 4,003 3,337 2,538 4,320 4,316 0.55%
PBT -41,873 -32,703 -26,512 -12,674 -11,328 -7,890 -2,160 63.86%
Tax 547 1,254 95 95 0 1,023 1,963 -19.17%
NP -42,420 -32,703 -26,512 -12,674 -11,328 -7,890 -2,160 64.21%
Tax Rate - - - - - - - -
Total Cost 46,881 41,089 30,515 16,011 13,866 12,210 6,476 39.06%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -950.91 -389.97 -662.30 -379.80 -446.34 -182.64 -50.03 63.32%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -20.31 -16.57 -20.66 -17.57 -21.00 -52.46 -11.48 9.97%
EPS Diluted -20.31 -16.57 -20.66 -17.57 -21.00 -52.46 -11.48 9.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.